(Q37124428)

18 August 2017

1 reference

title

Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease (English)

1 reference

18 August 2017

0 references

1 reference

John E Donahue

1

1 reference

18 August 2017

Conrad E Johanson

series ordinal

2

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Journal of Neuropathology & Experimental Neurology

18 August 2017

published in

1 reference

18 August 2017

volume

67

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

261-270

1 reference

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

The integrity of the blood-brain barrier in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Clearing amyloid through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Coaxing the LDL receptor family into the fold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

LRP and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

beta-Amyloid efflux mediated by p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Identification of agrin, a synaptic organizing protein from Torpedo electric organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

Clearance of amyloid-beta by circulating lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

The heparan sulfate proteoglycan agrin modulates neurite outgrowth mediated by FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31816A0DC8

10.1097/NEN.0B013E31816A0DC8

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference